|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang T, Nelson RA, Bogardus A and Grannis
FW Jr: Five-year lung cancer survival: Which advanced stage
nonsmall cell lung cancer patients attain long-term survival?
Cancer. 116:1518–1525. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guo H, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wilson RC and Doudna JA: Molecular
mechanisms of RNA interference. Annu Rev Biophys. 42:217–239. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bueno MJ, Pérez de Castro I and Malumbres
M: Control of cell proliferation pathways by microRNAs. Cell Cycle.
7:3143–3148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee CT, Risom T and Strauss WM: MicroRNAs
in mammalian development. Birth Defects Res C Embryo Today.
78:129–139. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jovanovic M and Hengartner MO: miRNAs and
apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lebanony D, Benjamin H, Gilad S, Ezagouri
M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, et
al: Diagnostic assay based on hsa-miR-205 expression distinguishes
squamous from nonsquamous non-small-cell lung carcinoma. J Clin
Oncol. 27:2030–2037. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Markou A, Tsaroucha EG, Kaklamanis L,
Fotinou M, Georgoulias V and Lianidou ES: Prognostic value of
mature microRNA-21 and microRNA-205 overexpression in non-small
cell lung cancer by quantitative real-time RT-PCR. Clin Chem.
54:1696–1704. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chao CH, Chang CC, Wu MJ, Ko HW, Wang D,
Hung MC, Yang JY and Chang CJ: MicroRNA-205 signaling regulates
mammary stem cell fate and tumorigenesis. J Clin Invest.
124:3093–3106. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Midorikawa Y, Yamamoto S, Tsuji S,
Kamimura N, Ishikawa S, Igarashi H, Makuuchi M, Kokudo N, Sugimura
H and Aburatani H: Allelic imbalances and homozygous deletion on
8p23.2 for stepwise progression of hepatocarcinogenesis.
Hepatology. 49:513–522. 2009. View Article : Google Scholar
|
|
15
|
Jiang F, Yin Z, Caraway NP, Li R and Katz
RL: Genomic profiles in stage I primary non small cell lung cancer
using comparative genomic hybridization analysis of cDNA
microarrays. Neoplasia. 6:623–635. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shen J, Liu Z, Todd NW, Zhang H, Liao J,
Yu L, Guarnera MA, Li R, Cai L, Zhan M, et al: Diagnosis of lung
cancer in individuals with solitary pulmonary nodules by plasma
microRNA biomarkers. BMC Cancer. 11:3742011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tan X, Qin W, Zhang L, Hang J, Li B, Zhang
C, Wan J, Zhou F, Shao K, Sun Y, et al: A 5-microRNA signature for
lung squamous cell carcinoma diagnosis and hsa-miR-31 for
prognosis. Clin Cancer Res. 17:6802–6811. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ragusa M, Majorana A, Statello L, Maugeri
M, Salito L, Barbagallo D, Guglielmino MR, Duro LR, Angelica R,
Caltabiano R, et al: Specific alterations of microRNA transcriptome
and global network structure in colorectal carcinoma after
cetuximab treatment. Mol Cancer Ther. 9:3396–3409. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, Tian X, Han R, Zhang X, Wang X,
Shen H, Xue L, Liu Y, Yan X, Shen J, et al: Downregulation of
miR-486-5p contributes to tumor progression and metastasis by
targeting protumorigenic ARHGAP5 in lung cancer. Oncogene.
33:1181–1189. 2014. View Article : Google Scholar :
|
|
20
|
Noviello C, Courjal F and Theillet C: Loss
of heterozygosity on the long arm of chromosome 6 in breast cancer:
Possibly four regions of deletion. Clin Cancer Res. 2:1601–1606.
1996.PubMed/NCBI
|
|
21
|
Hu XY, Bai XM, Qiao X and Zhu YQ: Copy
number variation at 6q13 is associated with lung cancer risk in a
Han Chinese population. Exp Lung Res. 39:427–433. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Agrawal R, Tran U and Wessely O: The
miR-30 miRNA family regulates Xenopus pronephros development and
targets the transcription factor Xlim1/lhx1. Development.
136:3927–3936. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu H, Wu H, Liu X, Li B, Chen Y, Ren X,
Liu Cg and Yang JM: Regulation of autophagy by a beclin 1-targeted
microRNA, miR-30a, in cancer cells. Autophagy. 5:816–823. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wettenhall JM and Smyth GK: limmaGUI: A
graphical user interface for linear modeling of microarray data.
Bioinformatics. 20:3705–3706. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Benjamini Y, Drai D, Elmer G, Kafkafi N
and Golani I: Controlling the false discovery rate in behavior
genetics research. Behav Brain Res. 125:279–284. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al The Gene Ontology Consortium: Gene ontology: Tool for the
unification of biology. Nat genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang B, Schmoyer D, Kirov S and Snoddy J:
GOTree Machine (GOTM): A web-based platform for interpreting sets
of interesting genes using Gene Ontology hierarchies. BMC
Bioinformatics. 5:162004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Draghici S, Khatri P, Tarca AL, Amin K,
Done A, Voichita C, Georgescu C and Romero R: A systems biology
approach for pathway level analysis. Genome Res. 17:1537–1545.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Varkonyi-Gasic E, Wu R, Wood M, Walton EF
and Hellens RP: Protocol: A highly sensitive RT-PCR method for
detection and quantification of microRNAs. Plant Methods. 3:122007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Belinsky SA, Liechty KC, Gentry FD, Wolf
HJ, Rogers J, Vu K, Haney J, Kennedy TC, Hirsch FR, Miller Y, et
al: Promoter hypermethylation of multiple genes in sputum precedes
lung cancer incidence in a high-risk cohort. Cancer Res.
66:3338–3344. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jiang F, Todd NW, Qiu Q, Liu Z, Katz RL
and Stass SA: Combined genetic analysis of sputum and computed
tomography for noninvasive diagnosis of non-small-cell lung cancer.
Lung Cancer. 66:58–63. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu Z, Zhao J, Chen XF, Li W, Liu R, Lei
Z, Liu X, Peng X, Xu K, Chen J, et al: CpG island methylator
phenotype involving tumor suppressor genes located on chromosome 3p
in non-small cell lung cancer. Lung Cancer. 62:15–22. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu Z, Li W, Lei Z, Zhao J, Chen XF, Liu
R, Peng X, Wu ZH, Chen J, Liu H, et al: CpG island methylator
phenotype involving chromosome 3p confers an increased risk of
non-small cell lung cancer. J Thorac Oncol. 5:790–797. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yu SL, Chen HY, Chang GC, Chen CY, Chen
HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, et al: MicroRNA
signature predicts survival and relapse in lung cancer. Cancer
Cell. 13:48–57. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microRNAs in human lung
cancers in association with shortened postoperative survival.
Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yu L, Todd NW, Xing L, Xie Y, Zhang H, Liu
Z, Fang H, Zhang J, Katz RL and Jiang F: Early detection of lung
adenocarcinoma in sputum by a panel of microRNA markers. Int J
Cancer. 127:2870–2878. 2010. View Article : Google Scholar
|
|
39
|
Scaruffi P, Parodi S, Mazzocco K,
Defferrari R, Fontana V, Bonassi S and Tonini GP: Detection of MYCN
amplification and chromosome 1p36 loss in neuroblastoma by cDNA
microarray comparative genomic hybridization. Mol Diagn. 8:93–100.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Patnaik SK, Kannisto E, Knudsen S and
Yendamuri S: Evaluation of microRNA expression profiles that may
predict recurrence of localized stage I non-small cell lung cancer
after surgical resection. Cancer Res. 70:36–45. 2010. View Article : Google Scholar
|
|
41
|
Zhang G, Liu Z, Cui G, Wang X and Yang Z:
MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in
breast cancer cells. Tumour Biol. 35:11137–11145. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pang W, Tian X, Bai F, Han R, Wang J, Shen
H, Zhang X, Liu Y, Yan X, Jiang F, et al: Pim-1 kinase is a target
of miR-486-5p and eukaryotic translation initiation factor 4E, and
plays a critical role in lung cancer. Mol Cancer. 13:2402014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang N, Wang X, Huo Q, Sun M, Cai C, Liu
Z, Hu G and Yang Q: MicroRNA-30a suppresses breast tumor growth and
metastasis by targeting metadherin. Oncogene. 33:3119–3128. 2014.
View Article : Google Scholar
|
|
44
|
Kumarswamy R, Mudduluru G, Ceppi P,
Muppala S, Kozlowski M, Niklinski J, Papotti M and Allgayer H:
MicroRNA-30a inhibits epithelial-to-mesenchymal transition by
targeting Snai1 and is downregulated in non-small cell lung cancer.
Int J Cancer. 130:2044–2053. 2012. View Article : Google Scholar
|
|
45
|
Võsa U, Vooder T, Kolde R, Vilo J,
Metspalu A and Annilo T: Meta-analysis of microRNA expression in
lung cancer. Int J Cancer. 132:2884–2893. 2013. View Article : Google Scholar
|
